Angiotensin converting enzyme inhibitors – benazepril

Last updated on October 7, 2022

Generic name

benazepril                                                 

Strength

5 mg, 10 mg, 20 mg
Form

tablet

Special Authority criteria

Approval period

1. Treatment failure on optimal doses of, or intolerance to, ramipril

     OR

2. Complex patient requiring medication(s) for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

  • Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
    • Pediatrics
    • Pediatric cardiology

Special notes

  • Patients with co-existing chronic condition(s) requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria

Special Authority request form(s)